LMP2-specific T-cell receptor-transduced autologous T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-014870
A preparation of autologous T lymphocytes that have been genetically modified to express a T-cell receptor (TCR) specific for the Epstein-Barr virus (EBV) latent membrane protein (LMP) 2, with potential immunomodulating and antineoplastic activities. Upon administration, LMP2-specific TCR-transduced autologous T lymphocytes recognize and bind to LMP2, which may promote cell death and inhibit the growth of tumor cells expressing LMP2. LMP2 is expressed in various EBV-associated malignancies.
| Identifier | MLC-T-ONC-014870 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | LMP2 antigen-specific TCR T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014870",
"term": "LMP2-specific T-cell receptor-transduced autologous T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that have been genetically modified to express a T-cell receptor (TCR) specific for the Epstein-Barr virus (EBV) latent membrane protein (LMP) 2, with potential immunomodulating and antineoplastic activities. Upon administration, LMP2-specific TCR-transduced autologous T lymphocytes recognize and bind to LMP2, which may promote cell death and inhibit the growth of tumor cells expressing LMP2. LMP2 is expressed in various EBV-associated malignancies.",
"synonyms": [
"LMP2 antigen-specific TCR T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lmp2-specific-t-cell-receptor-transduced-autologous-t-lymphocytes/"
}
Record 10,250 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.